Next Article in Journal / Special Issue
Olaparib Combined with an ATR or Chk1 Inhibitor as a Treatment Strategy for Acquired Olaparib-Resistant BRCA1 Mutant Ovarian Cells
Previous Article in Journal
BRCAness as an Important Prognostic Marker in Patients with Triple-Negative Breast Cancer Treated with Neoadjuvant Chemotherapy: A Multicenter Retrospective Study
Previous Article in Special Issue
Accuracy in Referrals to Gynecologic Oncologists Based on Clinical Presentation for Ovarian Mass
Open AccessReview

Article Versions Notes

Diagnostics 2020, 10(2), 120; https://doi.org/10.3390/diagnostics10020120
Action Date Notes Link
article xml file uploaded 22 February 2020 11:11 CET Update https://www.mdpi.com/2075-4418/10/2/120/xml
article pdf uploaded. 22 February 2020 11:11 CET Updated version of record https://www.mdpi.com/2075-4418/10/2/120/pdf
article xml file uploaded 29 February 2020 03:25 CET Update https://www.mdpi.com/2075-4418/10/2/120/xml
article xml uploaded. 29 February 2020 03:25 CET Update https://www.mdpi.com/2075-4418/10/2/120/xml
article pdf uploaded. 29 February 2020 03:25 CET Updated version of record https://www.mdpi.com/2075-4418/10/2/120/pdf
article html file updated 29 February 2020 03:27 CET Update https://www.mdpi.com/2075-4418/10/2/120/html
article html file updated 7 March 2020 11:26 CET Update https://www.mdpi.com/2075-4418/10/2/120/html
article html file updated 7 March 2020 15:39 CET Update https://www.mdpi.com/2075-4418/10/2/120/html
Back to TopTop